top of page

INDEPENDENT RESEARCH MEDIA HOUSE FOR THE ASX. DEPTH OVER HYPE.
Search


A Personalised Cancer Vaccine Meets Its Goal in Phase 3, and the ASX Companies Working With the Immune System
Merck and Moderna's personalised mRNA cancer vaccine cut the risk of melanoma returning or death by 42% in a Phase 3 trial. Here is what the trial showed, and where Immutep and Noxopharm are with their immunotherapy work.

Noel Ong
6 hours ago9 min read


Lumos Diagnostics (ASX: LDX) - The FebriDx Test, the Evidence and the US Rollout
The FebriDx test from Lumos Diagnostics (ASX LDX) helps tell bacterial from non-bacterial respiratory infections. Samso reads the trials and the cash.

Noel Ong
6 hours ago33 min read


Theranostics on the ASX, From Telix and Clarity to the Smaller Radiopharmaceutical Names
Theranostics on the ASX in 2026, where Telix, Clarity, Radiopharm, Cyclopharm and OncoSil stand as radiopharmaceuticals move from trials to sales.

Noel Ong
3 days ago9 min read


Radiopharmaceuticals and the State of Biotech in 2026
Radiopharmaceuticals are the 2026 biotech area closest to sales for ASX investors. How cancer vaccines, gene editing and AI drug discovery compare.

Noel Ong
4 days ago9 min read


Recce Pharmaceuticals (ASX: RCE) - The Science Behind R327 and the Phase 3 Review Ahead
Recce Pharmaceuticals' synthetic antibiotic R327, what its Phase 3 trials have and have not shown, the Arrotex licence, and the cash, debt and AGM.

Noel Ong
4 days ago37 min read


Island Pharmaceuticals (ASX: ILA) - Galidesivir, Marburg and the Ebola Outbreak
Island Pharmaceuticals (ASX ILA) is taking galidesivir to the FDA for Marburg. We cover the monkey data, the Ebola outbreak, the timeline and the cash.

Noel Ong
5 days ago34 min read


Clever Culture Systems (ASX: CC5) - The AI Plate Reader, Its Pharma Customers and the Cash
Clever Culture Systems (ASX CC5) sells an AI plate reader to AstraZeneca and Pfizer. Samso reads the customer data, the PSC Biotech deal and the cash.

Noel Ong
6 days ago34 min read


The Business of FDA Approvals
The FDA approval process explained for drugs, devices and tests. What approval gives a company, what it does not, and the ASX record.

Noel Ong
Nov 247 min read


ASX AI Stocks Where AI Is the Product
Samso counts 25 ASX companies whose main product is AI. Together they are worth A$2.2 billion, and most are small caps.

Noel Ong
Nov 29 min read


Cleo Diagnostics (ASX: COV) - The Ovarian Cancer Blood Test, the Evidence and the FDA Submission
Cleo Diagnostics (ASX COV) plans an FDA submission for its ovarian cancer blood test in the first half of 2027. Samso reads the evidence and the cash.

Noel Ong
Oct 2846 min read
bottom of page